1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA PLOD2 CTRPv2 pan-cancer AAC -0.15 0.0003
mRNA ITPR2 CTRPv2 pan-cancer AAC -0.13 0.0003
mRNA HES2 CTRPv2 pan-cancer AAC 0.14 0.0003
mRNA FRAT2 CTRPv2 pan-cancer AAC 0.14 0.0003
mRNA GRK2 CTRPv2 pan-cancer AAC 0.16 0.0003
mRNA IGSF6 CTRPv2 pan-cancer AAC 0.13 0.0003
mRNA TGFB1I1 CTRPv2 pan-cancer AAC -0.15 0.0003
mRNA PHLDA3 CTRPv2 pan-cancer AAC 0.14 0.0003
mRNA OR2A7 CTRPv2 pan-cancer AAC 0.14 0.0003
mRNA FAM109A CTRPv2 pan-cancer AAC 0.14 0.0003
Download CSV